Vaginal Dryness and Menopause: The Most Treatable Symptom Nobody Mentions

Here is one of the strangest mismatches in women’s health: a symptom that affects at least half of women entering menopause — with 1 in 4 saying it spills into sleep, sexual health, or general happiness (Cleveland Clinic) — responds better to treatment than almost anything else in the transition, and goes unmentioned in most doctor’s appointments, by both parties, indefinitely.

So this article will be matter-of-fact, because the topic deserves it and the fix is too good to stay unspoken.

What’s happening

Vaginal and vulval tissue is among the most estrogen-dependent in the body. As levels fall, the tissue becomes thinner, drier, less elastic, and more easily irritated; natural lubrication declines; the local pH shifts. Medicine now bundles this with its frequent companions — urinary urgency, burning, recurrent UTIs — under one name: GSM, genitourinary syndrome of menopause (The Menopause Society). One cause, several expressions.

It can feel like: dryness or itching in daily life, discomfort with underwear or exercise, stinging with soap or urine, discomfort or pain with sex, or just a general awareness of tissue that never used to announce itself.

Two facts set GSM apart from the transition’s other symptoms:

1. It doesn’t fade on its own. Hot flashes are driven by hormonal fluctuation and settle in postmenopause. GSM is driven by the low-estrogen state — untreated, it persists or progresses.
2. It’s the most treatable symptom on the list. Which makes the silence around it genuinely costly.

What works

Local (vaginal) estrogen is the cornerstone (NHS): creams, pessaries, tablets, or a slow-release ring delivering a tiny dose directly to the tissue. It restores thickness, elasticity, and moisture over a few weeks to months. Because so little enters the bloodstream, it’s considered safe for long-term use for most women — this is a different decision from systemic HRT, with a different (much smaller) risk profile. It also meaningfully reduces recurrent UTIs, which alone changes lives.

(After hormone-sensitive cancer, the calculus is individual — oncology teams increasingly have pathways for exactly this, and the non-hormonal options below still apply.)

Non-hormonal help:

• Vaginal moisturizers (regular use, not just before sex) improve baseline comfort
• Lubricants for intimacy — water- or silicone-based; generous application is the entire technique
• Skip the soap — plain water or gentle emollient washes; fragranced products on thinned tissue are arson
• Staying sexually active, alone or partnered, genuinely helps maintain tissue elasticity and blood flow — use it or lose it has an evidence base here

Prescription alternatives (DHEA pessaries, oral ospemifene) exist for specific situations — more options on the specialist shelf if first-line ones don’t fit.

A private symptom deserves a private record

If you’re tracking your transition, dryness belongs in the log like anything else — it’s data, and its trajectory (better with treatment? worse without?) is exactly what a follow-up appointment needs. In Cyclora it stays where you put it: your private record, never in notifications, never in anything partner-facing. Quick-access surfaces don’t include it by default; sensitive stays sensitive.

The two-sentence appointment

“I have vaginal dryness and discomfort, and I understand local estrogen works well — can we talk about it?” That’s the whole script. GSM is routine for any menopause-literate clinician; if you’re met with awkwardness instead of options, that’s a signal about the clinician, not about you.

See a doctor promptly (rather than routinely) for: bleeding, discharge that’s new or unusual, sores or lumps, or pain that’s severe — those need assessment rather than moisturizer.